Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Overcoming the divide between ataxias and spastic paraplegias: shared phenotypes, genes, and pathways
Autosomal‐dominant spinocerebellar ataxias, autosomal‐recessive spinocerebellar ataxias,
and hereditary spastic paraplegias have traditionally been designated in separate …
and hereditary spastic paraplegias have traditionally been designated in separate …
Endo‐lysosomal and autophagic dysfunction: a driving factor in Alzheimer's disease?
LS Whyte, AA Lau, KM Hemsley… - Journal of …, 2017 - Wiley Online Library
Alzheimer's disease (AD) is the most common cause of dementia, and its prevalence will
increase significantly in the coming decades. Although important progress has been made …
increase significantly in the coming decades. Although important progress has been made …
Long-read sequencing of 3,622 Icelanders provides insight into the role of structural variants in human diseases and other traits
Long-read sequencing (LRS) promises to improve the characterization of structural variants
(SVs). We generated LRS data from 3,622 Icelanders and identified a median of 22,636 SVs …
(SVs). We generated LRS data from 3,622 Icelanders and identified a median of 22,636 SVs …
History, genetic, and recent advances on Krabbe disease
ACE Graziano, V Cardile - Gene, 2015 - Elsevier
Krabbe disease or globoid cell leukodystrophy is one of the classic genetic lysosomal
storage diseases with autosomal recessive inheritance that affects both central and …
storage diseases with autosomal recessive inheritance that affects both central and …
Krabbe disease successfully treated via monotherapy of intrathecal gene therapy
AM Bradbury, JH Bagel, D Nguyen, EA Lykken… - The Journal of clinical …, 2020 - jci.org
Globoid cell leukodystrophy (GLD; Krabbe disease) is a progressive, incurable
neurodegenerative disease caused by deficient activity of the hydrolytic enzyme …
neurodegenerative disease caused by deficient activity of the hydrolytic enzyme …
Newborn screening for Krabbe disease in New York State: the first eight years' experience
JJ Orsini, DM Kay, CA Saavedra-Matiz… - Genetics in …, 2016 - nature.com
Purpose: Krabbe disease (KD) results from galactocerebrosidase (GALC) deficiency.
Infantile KD symptoms include irritability, progressive stiffness, developmental delay, and …
Infantile KD symptoms include irritability, progressive stiffness, developmental delay, and …
Tuning protein folding in lysosomal storage diseases: the chemistry behind pharmacological chaperones
Misfolding of proteins is the basis of several proteinopathies. Chemical and pharmacological
chaperones are small molecules capable of inducing the correct conformation of proteins …
chaperones are small molecules capable of inducing the correct conformation of proteins …
[HTML][HTML] Second-generation pharmacological chaperones: beyond inhibitors
ML Tran, Y Génisson, S Ballereau, C Dehoux - Molecules, 2020 - mdpi.com
Protein misfolding induced by missense mutations is the source of hundreds of
conformational diseases. The cell quality control may eliminate nascent misfolded proteins …
conformational diseases. The cell quality control may eliminate nascent misfolded proteins …
Brain-targeted enzyme-loaded nanoparticles: A breach through the blood-brain barrier for enzyme replacement therapy in Krabbe disease
Lysosomal storage disorders (LSDs) result from an enzyme deficiency within lysosomes.
The systemic administration of the missing enzyme, however, is not effective in the case of …
The systemic administration of the missing enzyme, however, is not effective in the case of …
Long-term neurodevelopmental outcomes of hematopoietic stem cell transplantation for late-infantile Krabbe disease
IC Yoon, NA Bascou, MD Poe… - Blood, The Journal …, 2021 - ashpublications.org
Krabbe disease is a rare neurodegenerative disorder caused by a deficiency in
galactocerebrosidase. The only effective treatment is hematopoietic stem cell transplantation …
galactocerebrosidase. The only effective treatment is hematopoietic stem cell transplantation …